PlexusDx semaglutide is compounded by licensed 503A pharmacies under pharmaceutical-grade standards, but compounded medications are not FDA-approved as finished products
Solubility Soluble in water, dimethyl formamide, ethanol, phosphate buffered saline, diluted alcohol, liquid ammonia and dimethyl sulfoxide
A clinical study demonstrates that semaglutide treatment led to a 1.38% drop in HbA1c, a 56.53 mg/dL reduction in fasting blood glucose, and an average weight loss of 6.03 kg after 32 weeks of treatment
Delphi Panellists Eligible panellists were actively practising healthcare professionals involved in treatment decision-making for adults with T2D and CKD in the following medical specialties: primary care, nephrology, endocrinology/diabetology, or internal medicine